⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Septodont and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Septodont
↗Saint-Maur-des-Fossés, France
Septodont is a global leader in the development, manufacturing, and distribution of dental products, particularly renowned for its local dental anesthetics. Founded in 1932 and remaining 100% family-owned, the company has expanded its expertise into pharmaceutical and medical device manufacturing, including bioactive and biocompatible therapeutic solutions like Biodentine.
Beyond its core dental business, Septodont operates a significant Contract Development and Manufacturing Organization (CDMO) division, primarily through its Canadian subsidiary, Novocol Pharma. This division specializes in aseptic fill-finish services for sterile injectables and combination products, serving a wide range of global biopharmaceutical partners.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Dental Pharmaceuticals & CDMO
SIZE & FINANCIALS
Employees:1001-5000
Founded:1932
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biomaterials
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Novocol Pharma, TDV, DLA Pharma, Duoject Medical Systems, Inibsa (controlling stake)
Key Partnerships:Balanced Pharma (Strategic investment in dental anesthesia innovation), Acteon (Joint shareholder in Inibsa)
COMPETITION
Position:Leader
Competitors:Dentsply Sirona, Straumann, Envista Holdings
LEADERSHIP
Key Executives:
Karim Khadr - CEO
Olivier Schiller - Chairman of the Board
Scientific Founders:Annie Schiller, Nestor Schiller
LINKS
Website:septodont.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Septodont. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.